Skip to main content
Irl Hirsch, MD, Endocrinology, Seattle, WA

Irl B Hirsch MD

Endocrinology•Seattle, WA

Diabetes, Lipid Metabolism

Professor of Medicine, University Wash

Join to view full profile

  • University Of Washington Diabetes Institue750 Republican, Building F, 3rd FloorSeattle, WA 98109

  • Phone+1 206-616-6732

Dr. Hirsch is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Hirsch's full profileAlready have an account?

Summary

  • Dr. Irl Hirsch is an endocrinologist based in Seattle, WA, with subspecialties in diabetes and lipid metabolism. He completed his fellowship in endocrinology, diabetes, and metabolism at the Washington University/B-JH/SLCH Consortium after graduating from the University of Missouri-Columbia School of Medicine in 1984. Dr. Hirsch has served as a Professor of Medicine at the University of Washington School of Medicine since 1990. His expertise lies primarily in diabetes and hypoglycemia, and he has been involved in multiple clinical trials and published extensively in prominent journals. Notable publications include work in The Lancet, New England Journal of Medicine, JAMA, and Diabetes Care, focusing on diabetes research methodologies and treatment innovations. He has been recognized with awards such as America's Top Doctors by Castle Connolly.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1984

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1990 - 2028
  • FL State Medical License
    FL State Medical License 1985 - 1987
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • America's Top Doctors Castle Connolly, 2009-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes  
    Anuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
  • Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020  
    Irl B Hirsch, Linda M Gaudiani, JAMA
  • Connecting the Dots: Validation of Time in Range Metrics with Microvascular Outcomes  
    Korey K Hood, Irl B Hirsch, Diabetes Care

Lectures

  • Advances in Therapy 
    2019 ACP Internal Medicine Meeting, Philadelphia - 4/10/2019
  • 1st Annual Diabetes Symposium: New Advances and Innovations 
    Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 9/28/2012
  • Pregnancy Complicated by Diabetes and Severe Insulin Resistance (SIR): Review of 8 Cases on U-500 Regular Insulin (U500) 
    Seattle, WA - 6/15/2014

Authored Content

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020
  • Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020May 2020

Press Mentions

  • Frequent CGM Use Results in Greater Glycemic Benefits for Adults with Type 2 Diabetes
    Frequent CGM Use Results in Greater Glycemic Benefits for Adults with Type 2 DiabetesNovember 26th, 2025
  • Automated Insulin Delivery Benefits Adults with Type 2 Diabetes Regardless of C-peptide Levels: Study Finds
    Automated Insulin Delivery Benefits Adults with Type 2 Diabetes Regardless of C-peptide Levels: Study FindsOctober 26th, 2025
  • Tandem Reports Positive Outcomes for Automated Insulin Delivery in Type 2 Regardless of C-peptide Levels
    Tandem Reports Positive Outcomes for Automated Insulin Delivery in Type 2 Regardless of C-peptide LevelsSeptember 16th, 2025

Committees

  • member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2031
  • member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
  • member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
  • member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
  • member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Irl Hirsch, Dr. Irl Hirsch, MD, Dr. I Hirsch, Dr. Irl B Hirsch